Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...

Please provide your email address to receive an email when new articles are posted on . Daily inhaled cannabis use significantly increased the likelihood for asthma and COPD in adults. The asthma ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

SPRINGFIELD, Ill. (WTVO) — Starting January 1st, 2026, Illinois residents will see new limits on what they pay for certain prescription drugs, a move lawmakers say could ease financial strain on ...

Early Exacerbations Tied to Poor Outcomes in Cystic Fibrosis Pulmonary exacerbations are common in children with cystic fibrosis during the first 3 years of life and are associated with lower lung ...

A mum-of-five who has battled asthma since she was just four months old and now lives with chronic obstructive pulmonary disease (COPD) endures hurtful comments from members of the public who mistake ...

COPD inhaled triple therapy (BDP/FF/G) improved symptoms, lung function, adherence, and QOL in patients previously treated with inhaled dual therapy.

Use of inhaled corticosteroids by pregnant mothers with asthma may protect infants against reduced lung function at 4 to 6 weeks of age.

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...